Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Microbiotica develops microbiome-based medicines that use selected gut bacteria for the treatment of cancer and inflammatory bowel diseases.
Salience Labs develops optical networking technology using silicon photonics, electronics, and machine learning.
CMR Surgical develops and manufactures robotic surgical systems to enhance precision and efficiency in minimally invasive surgery.
TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.
Undo is a technology company that offers time travel debugging services for Linux.
Storm Therapeutics develops small-molecule therapies that target RNA-modifying enzymes to treat cancer and other diseases.
Trent AI is an agentic AI safety platform that provides unnoticed, automatic protection for LLMs and AI processes.
Immutrin is a biotech developing next‑generation antibody therapies to clear amyloid deposits and reverse amyloidosis.
Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.
T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.
Pretzel Therapeutics mission is to develop groundbreaking therapies to reverse mitochondrial dysfunction through mitochondrial biology.
Sortera Bio operates as a biotechnology company.
Mosaic Therapeutics is an oncology therapeutics company that develops targeted combination therapies for cancer patients.
PervasID is developing a high reliability
Cambridge GaN Devices is a semiconductor company focused on developing GaN power devices aimed at creating greener electronics.
Forefront RF is a fabless semiconductor company.
Epitopea is a transatlantic cancer immunotherapeutics company.
Riverlane develops software solutions to harness the power of quantum computers for practical applications.
Machine learning for automotive innovators
Phosphor AI provides personalized AI tutoring solutions for secondary education.
Complement Therapeutics operates as a preclinical stage company.
Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.
Seldon is a machine learning deployment platform.
Origami is an intelligent trading and automation software for short term power trading.
Cambridge Innovation Capital has invested in 52 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Cambridge Innovation Capital's top investment sectors include Biotechnology, Medical, Life Science, Therapeutics, Health Care. The firm invests across 35 different industry categories.
Among tracked funding rounds, CMR Surgical received $400.0M in a Corporate Round round. Cambridge Innovation Capital's total known invested capital is $1.8B.
Cambridge Innovation Capital's average investment size is $33.8M across its portfolio of 52 companies.
Recent Cambridge Innovation Capital portfolio additions include Microbiotica, Salience Labs, CMR Surgical, TRIMTECH Therapeutics, Undo. These companies were founded in 2020 or later.